from Reuters: Health News https://ift.tt/2qkk18a
Alkermes' depression treatment fails to get FDA panel backing
An advisory panel to the U.S. Food and Drug Administration on Thursday voted against approving Alkermes Plc's treatment for depression in patients with an inadequate response to standard antidepressant therapies.
from Reuters: Health News https://ift.tt/2qkk18a
from Reuters: Health News https://ift.tt/2qkk18a
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Stocks poised for another day of gains Equity markets look to add to the gains from the prior session as investor concerns about the fu...
-
By LIAM STACK from NYT Magazine https://ift.tt/2FNPp6k
No comments:
Post a Comment